Project Details
Projekt Print View

SFB 1382:  Gut-liver axis – Functional circuits and therapeutic targets

Subject Area Medicine
Biology
Chemistry
Term since 2019
Website Homepage
Project identifier Deutsche Forschungsgemeinschaft (DFG) - Project number 403224013
 
The gut-liver axis refers to the cooperative function and mutual interaction between gut and liver, including their exchange of cellular and molecular components such as microbial metabolites, nutritional substrates, immune cells, and mediators such as cytokines. The gut-liver axis is not only important for health but it also contributes to the pathogenesis and progression of many important human diseases. However, molecular and cellular circuits underlying the gut-liver axis are still poorly described. The mission of this CRC is to elucidate these functional circuits and, on this basis, to define new molecular and immunological strategies for prevention, diagnostics and treatment. In the second funding period, a particular scientific focus is placed on understanding the multi-layered functional and structural barriers of the gut-liver axis. CRC1382 projects investigate cellular, dietary, immunological, and microbial mechanisms that modulate them. This includes the analysis of barrier function by experimental approaches and clinical imaging as well as investigation of early life events that shape the establishment of barriers. A second focus is placed on investigating dynamic changes within the gut-liver axis. CRC 1382 projects will delineate the underlying events triggering and precipitating dynamic processes along the gut-liver axis. Specifically, we will build on our established expertise in bile acid analytics and employ human sample collections to describe dynamic changes in the bile acids pool by computational models and study their role during liver regeneration. Processes of immune adaptation will be studied by high-resolution approaches such as single-cell sequencing complemented by higher throughput methods to analyse larger numbers of samples. With respect to the gut microbiome as a key component of the gut-liver axis, CRC 1382 will obtain unique clinical insights and samples from a faecal microbiota transfer study in patients with decompensated cirrhosis. New technical developments within the CRC 1382 core projects will enable the implementation of individualised collections of cultured gut microbes and integrate artificial intelligence for the analysis and interpretation of imaging data. Considering the ever-increasing clinical relevance of the gut-liver axis, CRC 1382 is ideally positioned to spur further developments in this field.
DFG Programme Collaborative Research Centres

Current projects

Completed projects

 
 

Additional Information

Textvergrößerung und Kontrastanpassung